What sector does Cansino Biologics Inc. (6185) operate in?
Cansino Biologics Inc. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Cansino Biologics Inc. (6185) current stock price?
As of the latest data, Cansino Biologics Inc. stock price is HK$33.04, with a previous close of HK$33.82. Cansino Biologics Inc. lost -HK$0.78 in the last trading session, representing a -2.31% loss.
What is Cansino Biologics Inc. (6185) current market capitalization?
Cansino Biologics Inc. market cap is approximately 4.38 billion.
What is Cansino Biologics Inc. (6185) Earnings Per Share (EPS)?
The trailing EPS is HK$0.03, and the forward EPS is HK$1.28.
What is Cansino Biologics Inc. (6185) Price-to-Earnings (P/E) ratio?
Cansino Biologics Inc. current P/E ratio is 1,108.72, with a forward P/E of 25.81.
What is Cansino Biologics Inc. (6185) EBITDA?
Cansino Biologics Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 14.70 million.
Does Cansino Biologics Inc. (6185) pay dividends?
No. Cansino Biologics Inc. does not pay a dividend.
How did Cansino Biologics Inc. (6185) perform in its most recent earnings report?
In the last report (December 31, 2025), Cansino Biologics Inc. posted an EPS surprise of -83.87% and a revenue surprise of -75%.
When is Cansino Biologics Inc. (6185) next earnings report?
Cansino Biologics Inc. is expected to release its next earnings report on March 31, 2026.
What is Cansino Biologics Inc. (6185) beta (volatility) score?
Cansino Biologics Inc. has a beta of 1.278, suggesting it is more volatile than the market.